FDA Inspection 605242 — New York Blood Center Enterprises

New York Blood Center Enterprises — FEI 2470902

The FDA completed an inspection of New York Blood Center Enterprises on Sep 4, 2009 in Westbury, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 4, 2009
Fiscal Year
2009
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Westbury, NY (United States)

Citations

IDCFRDescription
135821 CFR 211.100(b)SOPs not followed / documented
311821 CFR 820.75(a)Documentation
441321 CFR 211.194(a)(8)Second person sign off

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.